Lack of association between human longevity and genetic polymorphisms in drug-metabolizing enzymes at the NAT2, GSTM1 and CYP2D6 loci

被引:0
作者
M.-L. Muiras
Patrick Verasdonck
Florence Cottet
François Schächter
机构
[1] Fondation Jean Dausset-CEPH,
[2] 27,undefined
[3] rue Juliette Dodu,undefined
[4] F-75010 Paris,undefined
[5] France,undefined
[6] DKFZ,undefined
[7] Abteilung F0100,undefined
[8] Im Neuenheimer Feld 242,undefined
[9] D-69120 Heidelberg,undefined
[10] Germany Tel.: +49-6221-42-4613; Fax: +49-6221-42-4962; e-mail: m.muiras@DKFZ-heidelberg.de,undefined
来源
Human Genetics | 1998年 / 102卷
关键词
Glutathione; Genetic Polymorphism; Genotype Distribution; Gene Deletion; Debrisoquine;
D O I
暂无
中图分类号
学科分类号
摘要
In the present study, the possible role of genetic polymorphism of three drug-metabolizing enzymes, debrisoquine/sparteine hydroxylase (CYP2D6), glutathione S-transferase μ (GSTM1), and N-acetyltransferase (NAT2), as a putative genetic component of human longevity, was explored. A total of 817 DNA samples from a centenarian and a control (20–70 years) population was subjected to PCR-coupled RFLP methods. Subjects were genotyped for the CYP2D6*3 (A2637 deletion) and CYP2D6*4 (G1934A transition) alleles, for four mutations of NAT2 [namely, NAT2*5A (C481T), NAT2*6A (G590A), NAT2*7A (G857A), and NAT2*14A (G191A)], and for the presence or absence of GSTM1 gene deletion. No significant difference was found at these three loci between centenarian and control subjects with respect to allelic variant frequencies, genotype distributions or predicted phenotypes deduced from genotype combinations. By comparing the distribution of combined genotypes for the polymorphisms tested at the CYP2D6, NAT2, and GSTM1 loci, none of the predicted phenotypes concerning debrisoquine hydroxylase extensive-metabolizer or poor-metabolizer phenotypes, slow or fast N-acetylation capacities, and active or defective glutathione S-transferase, could be correlated with human longevity, alone or in combination.
引用
收藏
页码:526 / 532
页数:6
相关论文
共 37 条
[31]   Association between CYP2D6 polymorphisms and lung cancer risk: an up-date meta-analysis [J].
Zeng, Jie ;
Li, Jianming ;
Bao, Meihua ;
Long, Yu ;
Li, Guangyi ;
Luo, Yueji .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (03) :4508-4517
[32]   Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10 [J].
Yoo, Hee-Doo ;
Lee, Sang-No ;
Kang, Hyun-Ah ;
Cho, Hea-Young ;
Lee, Il-Kwon ;
Lee, Yong-Bok .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (2B) :433-443
[33]   Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety [J].
Samer, C. F. ;
Daali, Y. ;
Wagner, M. ;
Hopfgartner, G. ;
Eap, C. B. ;
Rebsamen, M. C. ;
Rossier, M. F. ;
Hochstrasser, D. ;
Dayer, P. ;
Desmeules, J. A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (04) :919-930
[34]   Associations between Selected ADRB1 and CYP2D6 Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias [J].
Moric-Janiszewska, Ewa ;
Smolik, Slawomir ;
Szydlowski, Leslaw ;
Kapral, Malgorzata .
MEDICINA-LITHUANIA, 2023, 59 (12)
[35]   CYP2D6 and ADRB1 genetic polymorphisms and the selection of antihypertensive beta-receptor blockers for hypertensive patients [J].
Chen, Keping ;
Li, Ying ;
Yang, Chuankun ;
Xiao, Peng ;
Li, Guochun ;
Xu, Yurong .
AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2023, 13 (04) :264-271
[36]   Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study [J].
Ju, Shang ;
Gao, Yu ;
Cao, Xin ;
Zhang, Xiao-Fu ;
Yan, Cheng-Cheng ;
Liu, Feng-Tong .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2017, 21 (09) :539-546
[37]   Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation [J].
Muderrisoglu, Ahmet ;
Babaoglu, Elif ;
Korkmaz, Elif Tugce ;
Ongun, Mert C. ;
Karabulut, Erdem ;
Iskit, Alper B. ;
Emri, Salih ;
Babaoglu, Melih O. .
FRONTIERS IN GENETICS, 2020, 11